RNRMarketResearch.com

11.8% for Vaccines Market to Reach 57,885.4 Million by 2019, Driven by Increasing Government Initiatives Across Globe

Press Release   •   May 27, 2016 04:52 EDT

The vaccine technology market by type is divided into preventive and therapeutic vaccines. Preventive vaccines accounted for the largest share of the market primarily due to the increasing prevalence of infectious diseases. In addition, increasing investments by government and non-government organizations to enhance vaccine research and supply doses worldwide will further enhance the growth of market.

Complete report on Vaccines Market spread across 220 Pages, Profiling 12 Companies and Supported with 145 Tables and 65 Figures is now available at http://www.reportsnreports.com/reports/267258-vaccine-market-by-technology-types-and-by-indications-infectious-diseases-cancer-allergy-diabetes-cardiovascular-disease-with-market-landscape-analysis-global-forecasts-to-2022.html .

The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. This market is segmented on the basis of type, technology, disease indication, end user, and geography. The global vaccine technology market involves different human vaccines that help in the prevention and treatment of diseases such as cholera, typhoid, and influenza.

Vaccines Market, by Technology

  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Subunit Vaccines
  • Recombinant Vector Vaccines
  • Inactivated Vaccines
  • Synthetic Vaccines
  • Dendritic Cells Vaccines

Vaccine technology market is driven by several factors which include high prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. The emerging market and increasing vaccine research have opened an array of opportunities for growth of the market. However, low accessibility to vaccines in remote areas and stringent regulatory procedures are expected to restrain the growth of market.

Interested in this report, Report copy of this research is available now

http://www.reportsnreports.com/contacts/requestsample.aspx?name=267258 .

The vaccine technology market by type is divided into preventive and therapeutic vaccines. Preventive vaccines accounted for the largest share of the market primarily due to the increasing prevalence of infectious diseases. In addition, increasing investments by government and non-government organizations to enhance vaccine research and supply doses worldwide will further enhance the growth of market.

Key players in the vaccine technology market include Bavarian Nordic (Denmark), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson and Johnson (U.S.), MedImmune, LLC (U.S.), Merck and Company (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), and Sanofi Pasteur (France).

Click now for more Details, Queries, Discount and Other Information on this study “Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=267258 .

Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries.

The emerging markets of the Asian region have opened an array of opportunities for the vaccines market. However, low accessibility to vaccines in remote areas and stringent regulatory procedures are expected to restrain the growth of this market.

About Us:

ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@reportsandreports.com